Intrinsiqs

Is Cogent Biosciences, Inc. overvalued?

Cogent Biosciences, Inc. (COGT) — key valuation metrics and fundamentals.

No verdict
Price
$32.31
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$5.52B
Dividend yield
0.0%
Return on equity
-72.6%
Sector
Healthcare

See the full interactive analysis →

Fair value compares COGT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.